Overview

Alkali Therapy in Chronic Kidney Disease

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
Kidney disease is a common medical condition. Individuals with kidney disease develop a build-up of acid in their blood. This acid can affect their muscles, bones, glucose metabolism and kidneys. The investigators will test alkali treatment, to treat acid build-up, in a randomized placebo-controlled clinical trial to evaluate effects on muscles, bones, glucose metabolism and kidney.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Albert Einstein College of Medicine
Albert Einstein College of Medicine of Yeshiva University
Collaborators:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institutes of Health (NIH)